FreshRecalls

FDAClass II · Drug · Recalled July 1, 2026

Sensipar (cinacalcet) Tablets recall — Amgen, Inc.

Hazard: CGMP Deviations

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0616-2026
Brand
Amgen
Classification
Class II
Units affected
N/A
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Sensipar (cinacalcet) Tablets, 90mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, Made in Japan. NDC 55513-075-30

Affected products

Companies & origin

Recalling firm location
Thousand Oaks, CA, United States
Firm address
1 Amgen Center Dr, N/A, 91320-1730

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 1157056, Exp. Date 02/29/2028
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
99077
Recall initiated
June 4, 2026
FDA classified
June 23, 2026
FDA report date
July 1, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page